(3-(C16-C18)ALKANESULFINYL- AND SULFONYL-2- METHOXYMETHYL-PROPYL)-(2-TRIMETHYLAMMONIO- ETHYL) PHOSPHATE, PRODUCTION THEREOF AND MEDICINE CONTAINING THAT COMPOUND

(3-(C16-C18)ALKANESULFINYL- AND SULFONYL-2- METHOXYMETHYL-PROPYL)-(2-TRIMETHYLAMMONIO- ETHYL) PHOSPHATE, PRODUCTION THEREOF AND MEDICINE CONTAINING THAT COMPOUND

NEW MATERIAL: A compound of formula I [(n) is 1 or 2; R is a 16-18C linear saturated alkyl], a stereoisomer thereof and a pharmaceutically acceptable salt thereof. USE: An antitumor agent. PROCESS: The compound is obtained by a method for reacting a compound of formula II capable of being a racemic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DEIITAA HERUMAN, ERUMAA BOSHIISU, URUFU POURUKE
Format: Patent
Sprache:eng
Schlagworte:
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:NEW MATERIAL: A compound of formula I [(n) is 1 or 2; R is a 16-18C linear saturated alkyl], a stereoisomer thereof and a pharmaceutically acceptable salt thereof. USE: An antitumor agent. PROCESS: The compound is obtained by a method for reacting a compound of formula II capable of being a racemic isomer or an enantiomer, with an oxidant, or by reacting a compound of formula III with a compound of formula IV (X is Cl; Y is Br or shows O with X) in the presence of an acid combining agent, and further treating the product with trimethylamine, etc.